{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T19:15:05Z","timestamp":1788462905766,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,3]]},"DOI":"10.7759\/cureus.115733","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:40:41Z","timestamp":1788460841000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Characteristics, Microbial Profile, and Factors Associated with Recurrent Urinary Tract Infections in Patients with Diabetes Mellitus: A Retrospective Cohort Study"],"prefix":"10.7759","author":[{"given":"Mya Ya","family":"Minn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humna","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima","family":"Shabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rijja","family":"Feroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najeeb","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Zain Ul","family":"Abideen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daud","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.87816","article-title":"Recurrent urinary tract infection in diabetics: a retrospective analysis","volume":"17","author":"Wajid H","year":"2025","unstructured":"Wajid H, Manzoor H, Manzoor M, Mirza S, Khan HS, Hassan S, Ali B. Recurrent urinary tract infection in diabetics: a retrospective analysis. Cureus. 2025, 17:e87816. 10.7759\/cureus.87816","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/IJAM.IJAM_83_20","article-title":"Clinical profile and risk factors of recurrent urinary tract infection in patients with type 2 diabetes","volume":"6","author":"Nabi T","year":"2020","unstructured":"Nabi T. Clinical profile and risk factors of recurrent urinary tract infection in patients with type 2 diabetes. Int J Acad Med. 2020, 6:301-308. 10.4103\/IJAM.IJAM_83_20","journal-title":"Int J Acad Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5464","article-title":"Clinical and microbiological profile of urinary tract infections in diabetic versus non-diabetic individuals","volume":"11","author":"Kumar R","year":"2019","unstructured":"Kumar R, Kumar R, Perswani P, Taimur M, Shah A, Shaukat F. Clinical and microbiological profile of urinary tract infections in diabetic versus non-diabetic individuals. Cureus. 2019, 11:e5464. 10.7759\/cureus.5464","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaf177","article-title":"IDF Diabetes Atlas 11th edition 2025: global prevalence and projections for 2050","volume":"41","author":"Duncan BB","year":"2025","unstructured":"Duncan BB, Magliano DJ, Boyko EJ. IDF Diabetes Atlas 11th edition 2025: global prevalence and projections for 2050. Nephrol Dial Transplant. 2025, 41:7-9. 10.1093\/ndt\/gfaf177","journal-title":"Nephrol Dial Transplant"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3588297","article-title":"Systematic review of literature examining bacterial urinary tract infections in diabetes","volume":"2022","author":"Paudel S","year":"2022","unstructured":"Paudel S, John PP, Poorbaghi SL, Randis TM, Kulkarni R. Systematic review of literature examining bacterial urinary tract infections in diabetes. J Diabetes Res. 2022, 2022:3588297. 10.1155\/2022\/3588297","journal-title":"J Diabetes Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.559595","article-title":"Susceptibility for some infectious diseases in patients with diabetes: the key role of glycemia","volume":"9","author":"Ch\u00e1vez-Reyes J","year":"2021","unstructured":"Ch\u00e1vez-Reyes J, Esc\u00e1rcega-Gonz\u00e1lez CE, Chavira-Su\u00e1rez E, et al.. Susceptibility for some infectious diseases in patients with diabetes: the key role of glycemia. Front Public Health. 2021, 9:559595. 10.3389\/fpubh.2021.559595","journal-title":"Front Public Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137105","article-title":"Pathology of diabetes-induced immune dysfunction","volume":"25","author":"Alexander M","year":"2024","unstructured":"Alexander M, Cho E, Gliozheni E, Salem Y, Cheung J, Ichii H. Pathology of diabetes-induced immune dysfunction. Int J Mol Sci. 2024, 25:7105. 10.3390\/ijms25137105","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-022-00644-9","article-title":"The prevalence of urinary tract infections in type 2 diabetic patients: a systematic review and meta-analysis","volume":"27","author":"Salari N","year":"2022","unstructured":"Salari N, Karami MM, Bokaee S, Chaleshgar M, Shohaimi S, Akbari H, Mohammadi M. The prevalence of urinary tract infections in type 2 diabetic patients: a systematic review and meta-analysis. Eur J Med Res. 2022, 27:20. 10.1186\/s40001-022-00644-9","journal-title":"Eur J Med Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.36.7.2881","article-title":"Diabetes mellitus and urinary tract infection: causative uropathogens, their antibiotic susceptibility pattern and the effects of glycemic status","volume":"36","author":"Ahmad S","year":"2020","unstructured":"Ahmad S, Hussain A, Khan MS, Shakireen N, Ali I. Diabetes mellitus and urinary tract infection: causative uropathogens, their antibiotic susceptibility pattern and the effects of glycemic status. Pak J Med Sci. 2020, 36:1550-1557. 10.12669\/pjms.36.7.2881","journal-title":"Pak J Med Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.03.035","article-title":"European Association of Urology guidelines on urological infections: summary of the 2024 guidelines","volume":"86","author":"Kranz J","year":"2024","unstructured":"Kranz J, Bartoletti R, Bruy\u00e8re F, et al.. European Association of Urology guidelines on urological infections: summary of the 2024 guidelines. Eur Urol. 2024, 86:27-41. 10.1016\/j.eururo.2024.03.035","journal-title":"Eur Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae296","article-title":"Review of the in vitro microbiological activity of mecillinam against common uropathogens in uncomplicated urinary tract infection: focus on resistant pathogens","volume":"11","author":"Lodise TP","year":"2024","unstructured":"Lodise TP, Kaye KS, Henriksen AS, Kahlmeter G. Review of the in vitro microbiological activity of mecillinam against common uropathogens in uncomplicated urinary tract infection: focus on resistant pathogens. Open Forum Infect Dis. 2024, 11:ofae296. 10.1093\/ofid\/ofae296","journal-title":"Open Forum Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac396","article-title":"Pivmecillinam, the paradigm of an antibiotic with low resistance rates in Escherichia coli urine isolates despite high consumption","volume":"78","author":"Frimodt-M\u00f8ller N","year":"2022","unstructured":"Frimodt-M\u00f8ller N, Simonsen GS, Larsen AR, Kahlmeter G. Pivmecillinam, the paradigm of an antibiotic with low resistance rates in Escherichia coli urine isolates despite high consumption. J Antimicrob Chemother. 2022, 78:289-295. 10.1093\/jac\/dkac396","journal-title":"J Antimicrob Chemother"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos AP","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, et al.. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012, 18:268-281. 10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"key":"ref14","article-title":"Performance Standards for Antimicrobial Susceptibility Testing. 35th Edition","author":"Lewis II","year":"2025","unstructured":"Lewis II, James S. Performance Standards for Antimicrobial Susceptibility Testing. 35th Edition.  Clinical and Laboratory Standards Institute, Wayne, PA; 2025."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2010.190","article-title":"The epidemiology of urinary tract infection","volume":"7","author":"Foxman B","year":"2010","unstructured":"Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010, 7:653-660. 10.1038\/nrurol.2010.190","journal-title":"Nat Rev Urol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13121218","article-title":"Prevalence of antimicrobial resistance among the WHO\u2019s AWaRe classified antibiotics used to treat urinary tract infections in diabetic women","volume":"13","author":"Hamdan A","year":"2024","unstructured":"Hamdan A, AbuHaweeleh MN, Al-Qassem L, et al.. Prevalence of antimicrobial resistance among the WHO\u2019s AWaRe classified antibiotics used to treat urinary tract infections in diabetic women. Antibiotics. 2024, 13:1218. 10.3390\/antibiotics13121218","journal-title":"Antibiotics"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S51792","article-title":"Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management","volume":"8","author":"Nitzan O","year":"2015","unstructured":"Nitzan O, Elias M, Chazan B, Saliba W. Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diabetes Metab Syndr Obes. 2015, 8:129-136. 10.2147\/DMSO.S51792","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11060861","article-title":"Prevalence and associated risk factors of urinary tract infection among diabetic patients: a cross-sectional study","volume":"11","author":"Ahmed AE","year":"2023","unstructured":"Ahmed AE, Abdelkarim S, Zenida M, et al.. Prevalence and associated risk factors of urinary tract infection among diabetic patients: a cross-sectional study. Healthcare (Basel). 2023, 11:861. 10.3390\/healthcare11060861","journal-title":"Healthcare (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59101747","article-title":"Particularities of urinary tract infections in diabetic patients: a concise review","volume":"59","author":"Confederat LG","year":"2023","unstructured":"Confederat LG, Condurache MI, Alexa RE, Dragostin OM. Particularities of urinary tract infections in diabetic patients: a concise review. Medicina. 2023, 59:1747. 10.3390\/medicina59101747","journal-title":"Medicina"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-017-2008-6","article-title":"Epidemiology of stone disease across the world","volume":"35","author":"Sorokin I","year":"2017","unstructured":"Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. Epidemiology of stone disease across the world. World J Urol. 2017, 35:1301-1320. 10.1007\/s00345-017-2008-6","journal-title":"World J Urol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles AL","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015, 13:269-284. 10.1038\/nrmicro3432","journal-title":"Nat Rev Microbiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-11714-8","article-title":"E. coli as a uropathogen in patients with diabetes mellitus, its prevalence and antimicrobial resistance profile in Ethiopia: a systematic review and meta-analysis","volume":"25","author":"Tesfaye NA","year":"2025","unstructured":"Tesfaye NA, Demessie MB, Hassen M, Solomon T, Andualem A, Gebreegziabher TL, Gobezie MY. E. coli as a uropathogen in patients with diabetes mellitus, its prevalence and antimicrobial resistance profile in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2025, 25:1276. 10.1186\/s12879-025-11714-8","journal-title":"BMC Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/517063-clinical-characteristics-microbial-profile-and-factors-associated-with-recurrent-urinary-tract-infections-in-patients-with-diabetes-mellitus-a-retrospective-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:40:43Z","timestamp":1788460843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/517063-clinical-characteristics-microbial-profile-and-factors-associated-with-recurrent-urinary-tract-infections-in-patients-with-diabetes-mellitus-a-retrospective-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.115733","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,3]]}}}